Kathryn D. Meyer received the National Institute on Drug Abuse (NIDA) 2018 Avenir Award for Genetics or Epigenetics Research. She will explore the role played by the biochemical modifications of a cell’s RNA in controlling drug-induced gene expression changes. NIDA’s Avenir Awards provide grants to early stage investigators who propose highly innovative studies. “Avenir” is the French word for “future”, and these awards represent NIDA’s commitment to supporting researchers who represent the future of addiction science. Awardees receive up to $300,000 per year for five years to support their projects.
Monday, October 15, 2018